| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3999403 | Urologic Oncology: Seminars and Original Investigations | 2016 | 8 Pages |
Abstract
The expression of miR-301a could be a potential marker for metastasis in CaP patients. Detecting miR-301a expression during diagnosis will avoid wait and watch timelines, thus preventing morbidity.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Chendil Ph.D., Trinath P. Ph.D., A.M. Sashi Ph.D., Suman Ph.D., Venkatesh Ph.D., Targhee J. M.D., Erin N. M.D., Shesh N. Ph.D., Jamie C. M.D., Houda M.D., Murali K. M.D.,